Quest Diagnostics
Quest Diagnostics Incorporated operates as a leading provider of diagnostic information services in the United States and select international markets. The company delivers a comprehensive range of clinical laboratory testing, drug screening, and health and wellness services to patients, employers, healthcare… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Quest Diagnostics does
In the company’s own words
Quest Diagnostics Incorporated operates as a leading provider of diagnostic information services in the United States and select international markets. The company delivers a comprehensive range of clinical laboratory testing, drug screening, and health and wellness services to patients, employers, healthcare providers, and other clients through an extensive network of patient service centers and laboratory facilities.
The company's core business centers on performing and processing laboratory tests that provide critical diagnostic information used by healthcare providers to guide patient treatment decisions. Quest Diagnostics maintains one of the largest networks of patient service centers in the country, enabling convenient access to testing services for millions of individuals annually. The company processes millions of test results daily across its laboratory infrastructure, which includes regional and specialty testing facilities equipped with advanced diagnostic technology.
Quest Diagnostics operates through multiple business segments serving distinct customer bases and use cases. The company provides clinical laboratory testing services to healthcare providers and patients, occupational health services including drug screening and health and safety testing for employers, and wellness services directed at consumers seeking preventive health information. The company also offers specialized testing in areas such as molecular diagnostics, esoteric testing, and pathology services.
The company's competitive advantages include its extensive geographic footprint with thousands of patient service centers, sophisticated laboratory information systems and technology infrastructure, established relationships with healthcare providers and major employers, and scale economies in test processing and distribution. Quest Diagnostics serves a diverse customer base including hospitals, physicians, employers, insurance companies, and individual consumers across the United States.
The company maintains significant operational scale with a substantial workforce distributed across numerous laboratory and patient service center locations nationwide. Quest Diagnostics generates revenue from multiple service lines, with clinical laboratory testing representing a substantial portion of total revenues, supplemented by contributions from occupational health services, wellness offerings, and other diagnostic services. The company's business model relies on high-volume test processing, efficient logistics networks, and technology-enabled service delivery to serve its broad customer base effectively.
Company details
- Sector
- Health Care
- Industry (SIC)
- Health Services
- Headquarters
- SECAUCUS, NJ
- Fiscal year end
- December
- CIK
- 1022079
- SIC
- 8071
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Quest Diagnostics — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Quest Diagnostics’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Quest Diagnostics’s bonds, as funds hold them
Funds report holding 12 issues of Quest Diagnostics’s debt, $878.68M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.37%, maturing 2026 to 2045.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Quest Diagnostics and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Quest Diagnostics's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Quest Diagnostics's last four quarterly filings that the numbers alone won't show?”
